A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Novartis Ag stock. As of the latest transaction made, Renaissance Technologies LLC holds 2,300,678 shares of NVS stock, worth $227 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares
2,300,678
Previous 2,499,782 7.96%
Holding current value
$227 Million
Previous $266 Million 0.56%
% of portfolio
0.42%
Previous 0.47%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$106.13 - $120.89 $21.1 Million - $24.1 Million
-199,104 Reduced 7.96%
2,300,678 $265 Million
Q2 2024

Aug 09, 2024

SELL
$92.57 - $107.37 $40.8 Million - $47.3 Million
-440,800 Reduced 14.99%
2,499,782 $266 Million
Q1 2024

May 13, 2024

BUY
$95.27 - $108.47 $9.77 Million - $11.1 Million
102,500 Added 3.61%
2,940,582 $284 Million
Q4 2023

Feb 13, 2024

BUY
$92.27 - $101.54 $18.6 Million - $20.4 Million
201,237 Added 7.63%
2,838,082 $287 Million
Q3 2023

Nov 14, 2023

BUY
$94.73 - $105.13 $26.7 Million - $29.6 Million
282,000 Added 11.98%
2,636,845 $269 Million
Q2 2023

Aug 11, 2023

SELL
$92.52 - $104.91 $64.1 Million - $72.7 Million
-692,599 Reduced 22.73%
2,354,845 $238 Million
Q1 2023

May 12, 2023

SELL
$80.03 - $92.81 $29.9 Million - $34.7 Million
-373,526 Reduced 10.92%
3,047,444 $280 Million
Q4 2022

Feb 13, 2023

BUY
$75.55 - $92.52 $18.1 Million - $22.1 Million
239,100 Added 7.51%
3,420,970 $310 Million
Q3 2022

Nov 14, 2022

SELL
$74.61 - $87.26 $44.9 Million - $52.5 Million
-601,500 Reduced 15.9%
3,181,870 $242 Million
Q2 2022

Aug 12, 2022

BUY
$80.52 - $93.75 $32.4 Million - $37.7 Million
402,200 Added 11.9%
3,783,370 $320 Million
Q1 2022

May 13, 2022

SELL
$80.11 - $90.62 $27.8 Million - $31.4 Million
-346,400 Reduced 9.29%
3,381,170 $297 Million
Q4 2021

Feb 11, 2022

BUY
$79.7 - $88.13 $33.5 Million - $37 Million
420,333 Added 12.71%
3,727,570 $326 Million
Q3 2021

Nov 12, 2021

BUY
$81.78 - $95.14 $73.4 Million - $85.4 Million
897,298 Added 37.23%
3,307,237 $270 Million
Q2 2021

Aug 13, 2021

BUY
$85.24 - $94.15 $3.38 Million - $3.73 Million
39,600 Added 1.67%
2,409,939 $220 Million
Q1 2021

May 13, 2021

SELL
$83.5 - $98.47 $199 Million - $235 Million
-2,387,994 Reduced 50.19%
2,370,339 $203 Million
Q4 2020

Feb 10, 2021

SELL
$78.07 - $94.43 $150 Million - $182 Million
-1,923,475 Reduced 28.79%
4,758,333 $449 Million
Q3 2020

Nov 13, 2020

SELL
$82.14 - $91.0 $132 Million - $147 Million
-1,612,800 Reduced 19.44%
6,681,808 $581 Million
Q2 2020

Aug 13, 2020

SELL
$80.93 - $91.1 $15.9 Million - $17.9 Million
-196,800 Reduced 2.32%
8,294,608 $724 Million
Q1 2020

May 14, 2020

BUY
$70.67 - $99.01 $134 Million - $187 Million
1,890,226 Added 28.63%
8,491,408 $700 Million
Q4 2019

Feb 13, 2020

BUY
$84.35 - $95.37 $118 Million - $133 Million
1,396,027 Added 26.82%
6,601,182 $625 Million
Q3 2019

Nov 13, 2019

BUY
$85.54 - $94.26 $97.2 Million - $107 Million
1,135,798 Added 27.91%
5,205,155 $452 Million
Q2 2019

Aug 12, 2019

BUY
$75.4 - $92.8 $64.5 Million - $79.3 Million
854,857 Added 26.59%
4,069,357 $372 Million
Q1 2019

May 14, 2019

SELL
$75.32 - $86.15 $21.2 Million - $24.3 Million
-281,998 Reduced 8.07%
3,214,500 $309 Million
Q4 2018

Feb 13, 2019

BUY
$73.66 - $82.02 $258 Million - $287 Million
3,496,498 New
3,496,498 $300 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $212B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.